Eric Karas
2022
In 2022, Eric Karas earned a total compensation of $222.6K as Chief Commercial Officer at ARS Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $147,600 |
|---|---|
| Salary | $68,333 |
| Other | $6,691 |
| Total | $222,624 |
Karas received $147.6K in non-equity incentive plan, accounting for 66% of the total pay in 2022.
Karas also received $68.3K in salary and $6.7K in other compensation.
Rankings
In 2022, Eric Karas' compensation ranked 5,232nd out of 5,625 executives tracked by ExecPay. In other words, Karas earned more than 7.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,232 out of 5,625 | 7th |
Division Manufacturing | 2,863 out of 3,053 | 6th |
Major group Chemicals And Allied Products | 1,323 out of 1,380 | 4th |
Industry group Drugs | 1,236 out of 1,281 | 4th |
Industry Pharmaceutical Preparations | 892 out of 927 | 4th |
Source: SEC filing on May 1, 2023.
Karas' colleagues
We found six more compensation records of executives who worked with Eric Karas at ARS Pharmaceuticals in 2022.
2022
Laura Shawver
ARS Pharmaceuticals
Chief Executive Officer
2022
Valerie Odegard
ARS Pharmaceuticals
Chief Scientific Officer
2022
Jonathan Piazza
ARS Pharmaceuticals
Chief Financial Officer
2022
Jeffrey Pepe
ARS Pharmaceuticals
Chief Executive Officer
2022
Richard MSEL
ARS Pharmaceuticals
Chief Executive Officer
2022
Sarina Tanimoto
ARS Pharmaceuticals